共 50 条
- [32] START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
- [33] Therapy for human immunodeficiency virus infection - What have we learned? NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15): : 1142 - 1144
- [34] Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08): : 702 - 710
- [36] Increased frequency of α-synuclein in the substantia nigra in human immunodeficiency virus infection Journal of NeuroVirology, 2009, 15 : 131 - 138
- [39] INCREASED DENOVO HEPATIC LIPOGENESIS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03): : 559 - 565
- [40] CARDIOVASCULAR MANIFESTATIONS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANTS AND CHILDREN AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (20): : 1489 - 1497